OHI:NYSE
Omega Healthcare Investors, Inc
$45.22
arrow_upward
+0.11%(+0.050) 1D
$45.06
arrow_downward
-0.35% (-0.16)bedtimeAfter hours
Closed: Oct 13, 4:00:03 PM GMT-4 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for OHI...
Open
$45.57
High
$45.76
Low
$44.88
Mkt. cap
13.70B
Avg. vol.
2.11M
Volume
0.00
Dividend
5.95%
Quarterly dividend
$0.67
Ex-dividend date
May 4, 2026
P/E ratio
16.15
52-wk high
$52.39
52-wk low
$39.26
EPS
$2.80
Beta
0.53
Shares outstanding
303.01M
No. of employees
69
Open
$45.57
High
$45.76
Low
$44.88
Mkt. cap
13.70B
Avg. vol.
2.11M
Volume
0.00
Dividend
5.95%
Quarterly dividend
$0.67
Ex-dividend date
May 4, 2026
P/E ratio
16.15
52-wk high
$52.39
52-wk low
$39.26
EPS
$2.80
Beta
0.53
Shares outstanding
303.01M
No. of employees
69
News stories
From web sources and news partners
Yahoo Finance
·
1 day ago
Better High-Yield Dividend Stock: Omega Healthcare vs. VICI Properties
About Omega Healthcare Investors, Inc
CEO-
Employees69
Founded1992
HeadquartersHunt Valley, Maryland, United States
SectorReal estate investment trust
Websiteomegahealthcare.com
Analyst ratings
Based on 11 analysts giving stock ratings to OHI in the past 3 months
Hold
Buy
4
Hold
5
Sell
2
12-month forecast
Based on 11 Wall Street analysts offering 12 month price targets for OHI in the last 3 months.
Highest
Current $45.22
$58.00 (+28.26%)
Average
$50.64 (+11.99%)
Lowest
$46.00 (+1.72%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Michael Goldsmith UBS | Buy | Reiterated | $52.00 | +15% | 10/13/2026 |
Richard Hightower Barclays | Sell | Maintained | $48.00 | +6.1% | 10/13/2026 |
Dave Rodgers Raymond James | Buy | Maintained | $53.00 | +17.2% | 10/06/2026 |
Michael Carroll RBC Capital | Hold | Maintained | $51.00 | +12.8% | 09/11/2026 |
John Kilichowski Wells Fargo | Hold | Reiterated | $48.00 | +6.1% | 09/01/2026 |
Vikram Malhotra Mizuho Securities | Hold | Maintained | $46.00 | +1.7% | 08/31/2026 |
Farrell Granath Bank of America Securities | Sell | Reiterated | $49.00 | +8.4% | 08/14/2026 |
Michael Lewis Truist Financial | Hold | Maintained | $47.00 | +3.9% | 08/13/2026 |
Nicholas Joseph Citi | Buy | Maintained | $58.00 | +28.3% | 08/04/2026 |
Nicholas Yulico Scotiabank | Hold | Maintained | $49.00 | +8.4% | 07/31/2026 |
Richard Anderson Cantor Fitzgerald | Buy | Reiterated | $56.00 | +23.8% | 07/31/2026 |
Unknown Analyst Raymond James | Buy | Initiated | $50.00 | +10.6% | 06/16/2026 |
Julien Blouin Goldman Sachs | Buy | Maintained | $63.00 | +39.3% | 06/02/2026 |
Juan C. Sanabria BMO Capital | Hold | Maintained | $52.00 | +15% | 05/03/2026 |
Unknown Analyst Berenberg Bank | Buy | Maintained | $53.00 | +17.2% | 02/20/2026 |
Last report
Jul 30, 2026
Fiscal period
Q2 2026
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
$1.22 / $0.48
+154.33%beat
arrow_upward
Revenue / Est. (USD)
314.26M / 273.86M
+14.75%beat
arrow_upward
Fiscal Q2 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 311.59M | 319.22M | 316.30M | 314.26M |
Cost of goods sold | -405.00K | 10.30M | 5.72M | 11.18M |
Cost of revenue | -405.00K | 10.30M | 5.72M | 11.18M |
Research and development expenses | - | - | - | - |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 23.78M | 24.46M | 26.02M | 42.00M |
Operating expense | 105.89M | 107.21M | 103.50M | 109.85M |
Total operating expenses | 105.49M | 117.51M | 109.22M | 121.03M |
Operating income | 206.10M | 201.71M | 207.08M | 193.23M |
Other non operating income | 16.84M | 16.42M | 1.08M | -7.22M |
EBT including unusual items | 189.44M | 174.10M | 163.68M | 384.29M |
EBT excluding unusual items | 162.91M | 169.19M | 162.16M | 142.43M |
Income tax expense | 4.48M | 2.13M | 5.11M | 4.62M |
Effective tax rate | 2.37% | 1.22% | 3.12% | 1.20% |
Other operating expenses | - | - | -6.66M | -13.99M |
Net income | 179.72M | 164.84M | 151.05M | 362.82M |
Net profit margin | 57.68% | 51.64% | 47.76% | 115.45% |
Earnings per share | 0.59 | 0.53 | 0.48 | 1.22 |
Interest and investment income | - | - | - | - |
Interest expense | -58.12M | -51.74M | -49.76M | -48.12M |
Net interest expenses | -58.12M | -51.74M | -49.76M | -48.12M |
Depreciation and amortization charges | 82.11M | 82.75M | 84.14M | 81.84M |
EBITDA | 288.22M | 284.46M | 291.22M | 275.07M |
Gain or loss from assets sale | -28.27M | -6.07M | -3.02M | -246.52M |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1